InforSense played host to customers, partners, and investors to hear how its flagship integrative analytics platform is providing new information-driven insights across a wide variety of industries
InforSense played host to customers, partners, and investors at its London headquarters last week to hear how its flagship integrative analytics platform, InforSense KDE, is successfully providing new information-driven insights across a wide variety of industries.
Presenters, including Stephen Calvert, vice president of cheminformatics at GlaxoSmithKline and Michael Liebman, executive director of the Windber Research Institute, highlighted some of the drug discovery, health care and financial contexts in which InforSense KDE is used as an enterprise environment for business-critical decision-making.
"Many industries face the same challenge of enabling decision-makers to access and use information in a way that keeps pace with changing business needs," said Yike Guo, CEO and founder of InforSense.
"InforSense's service-oriented workflow technology effectively addresses this challenge by enabling the creation of a single platform to support entire information-driven decision-making processes.
"We see InforSense KDE increasingly adopted by companies in a wide range of sectors as a uniform environment for enterprise-wide decision support".
InforSense describes itself as a leader in integrative analytics, enabling organisations to orchestrate and optimise their business-critical decision-making processes.
Leading pharmaceutical and biotechnology, consumer goods, and financial services companies, and research institutes are using the company's flagship product, InforSense KDE, to enhance productivity across life science R and D, health care, and business analytics.
